Cite

HARVARD Citation

    Ohuchi, K. et al. (2020). Serum CCL22 levels decreased in parallel with disease activity in CCR4‐positive mycosis fungoides treated with mogamulizumab. Dermatologic therapy. 33 (6), p. n/a. [Online]. 
  
Back to record